Friday, March 29, 2019

Non-Surgical Skin Tightening Market Opportunity will Rise to US$ 500 Mn by 2022

Transparency Market Research (TMR) has published yet another insightful, comprehensive and objective report on the global non-surgical skin tightening market. This report offers a thorough briefing on the non-surgical skin tightening market, and comprises exhaustive discussion on latest trends influencing expansion of the market across the globe. The data around various parameters is analyzed in order to reach accurate and relevant numbers concerning the global non-surgical skin tightening market.
The competition landscape of the market has been included in the report, which renders detailed analysis on active companies operating in the market. The report provides decisive outlook of the global market for non-surgical skin tightening in terms of its historical performance and present conditions. Future potential of the market is also evaluated by the report in detail, for providing readers with forecasts and projections.
Report Synopsis
The report’s commencing chapter includes the executive summary, delivering an overall snapshot of the non-surgical skin tightening market to provide imperative information related to various regional and product segments analyzed within the report’s scope. This chapter provides with the most significant pertinent market numbers including the CAGR for 2012 to 2016 as well as the CAGR for 2017 to 2022. Lucrative markets have been analyzed on the basis of largest revenue shares and fastest expansion in this chapter.
Following the executive summary, a formal definition of “non-surgical skin tightening” has been rendered, along with a brief introduction of the market. Proceeding further the report delivers information about key market dynamics of the non-surgical skin tightening, covering key points such as bottom line of enterprises, fiscal stimulus and the global economy. Information on pricing and cost structure analysis of the market has also been given in the report.
Market Taxonomy
Few chapters of the report are dedicated to the segmentation analysis of the global non-surgical skin tightening market. The market has been segmented basically into three criteria viz. product, end-users and region. Revenue comparision, and market share comparision, along with a year-on-year growth comparison are key analytical methods utilized for arriving at imperative market numbers related to all the segments. Asia-Pacific excluding Japan (APEJ), North America, Europe, Latin America, Middle East and Africa (MEA), and Japan are key regions included in the report, on the basis of which future prospects of the market have been delivered.
Competition Landscape
The competition landscape is a valuable chapter of the report, providing detailed insights about functioning of active companies in the market. This concluding chapter of the report renders information on strategies utilized by companies for gaining a competitive edge, and staying at the forefront of the market. SWOT analysis has been done on key players in the market, along with other necessary data such as key financials, key developments, product overview, and company overview. Presence of leading market participants has been portrayed through an intensity map.
Research Methodology
A tested & proven research methodology has been adhered to by analysts at TMR for deriving revenue estimates pertaining to the global non-surgical skin tightening market. Secondary research, which is in-depth and extensive, has been carried out for arriving at overall market size, and for determining top market players. Exhaustive primary interviews conducted by TMR’s analysts with industry and domain experts have led towards provision of detailed forecast and analysis of the market that is delivered in this report. Data aggregated through primary and secondary research are validated thoroughly, and inspected using advanced tools for reaching at pertinent insights on the global market for non-surgical skin tightening market for the forecast period 2017 to 2022.

Posted by at No comments:

Cellular Health Screening Market to Attain a Value of US$ 3.1 Bn by 2025

Global Cellular Health Screening Market: Overview
The global cellular health screening market report provides readers with a comprehensive understanding of the development prospects of the market in the coming years with the help of solid historical information illustrating the past growth trajectory of the cellular health screening market. Latest figures of the global cellular health screening market are provided in the report in order to  acquaint readers with the structure and composition of the market’s most recent position. The growth trajectory of the cellular health screening market from 2012 to 2017 is assessed in the report in order to provide analysts with a solid foundation for 2017-2022 forecasts regarding the likely growth of the cellular health screening market.
The global cellular health screening market is likely to reach a valuation of US$2.1 bn by the end of 2017. According to Transparency Market Research, the global cellular health screening market is expected to exhibit a strong 8% CAGR between 2017 and 2022 to rise to a valuation of US$3.1 bn.
Global Cellular Health Screening Market: Dynamics
The key drivers and restraints determining the growth prospects of the global cellular health screening market are assessed in the report to help readers understand which factors are likely to aid and hinder their growth prospects in the cellular health screening market in the coming years. The cellular health screening market is affected by a number of factors determining the development of the healthcare sector across the world both positively and negatively. The report provides a detailed look into the extent of the effect each factor is likely to have on the global cellular health screening market in the coming years, illustrating the interrelation between the growth trajectory of the cellular health screening market and the various factors affecting it in the coming years.
Global Cellular Health Screening Market: Segmentation
The report takes a close look at the leading segments of the global cellular health screening market in order to familiarize with the leading revenue generators in the market. The 2012-2017 growth trajectory of key segments of the cellular health screening market is described in detail in the report to provide readers with a clear picture of the granular composition of the market. The report segments the global cellular health screening market by test type and sample type in order to elucidate the various components of the global market. The geographical distribution of the global cellular health screening market is also studied in depth in the report to provide readers with pointers on which regions are likely to hold promising opportunities in the coming years.
By test type, the global cellular health screening market is segmented into telomere tests, oxidative stress tests, inflammation tests, heavy metal tests, and multi-test panels. The key sample types used for cellular health screening include blood and body fluids. Geographically, the global cellular health screening market is segmented into North America, Latin America, Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa.
Global Cellular Health Screening Market: Competitive Dynamics
The report provides special attention to the competitive dynamics of the global cellular health screening market in order to help readers understand the ups and downs lying in store for them in the cellular health screening market in the coming years. The competitive strategies of leading players and their geographical presence is assessed in the report. Key companies profiled in the report include Quest Diagnostics Incorporated, Bio-Reference Laboratories Inc., Cell Science Systems Corporation, Cleveland HeartLab Inc., Genova Diagnostics Inc., Laboratory Corporation of America Holdings, Life Length S.L., and SpectraCell Laboratories Inc.

Posted by at No comments:

Medical Imaging Information System Market is Anticipated to Reach a Value of US$ 993.6 Mn by 2022

Global Medical Imaging Information System Market: Overview
The significant rise in the need for efficient management of medical imagery and associated information and data has fueled the demand for medical imaging information systems across the world. This research report presents a detailed assessment and forecast of this market, underlining its performance in various regions. It further provides the historical data of regarding this market while forecasting its status during the period of 2017 to 2022. The driving and restraining factors of this market, coupled with, their impact on the demand for these systems during the forecast period is discussed here with high importance. A thorough study of the opportunities available in this market on the global as well as the regional level has also been included in the market report.
In an effort to offer the readers of this research report with a comprehensive overview of this market, researchers have included an in-depth competitiveness analysis and information about the unique selling propositions of the leading players. Further, the report includes analyses of the market’s attractiveness and basis point share on the basis of the end-use, type, and power class of medical imaging information systems. The market numbers have also been estimated in this study on the basis of the average usage of medical imaging information systems in various application areas.
The market size and predictions for each of the segment have been offered in the context of the global and domestic markets. The dynamics of medical imaging information systems market Japan, Asia Pacific excluding japan, North America, Europe, and the Middle East and Africa have been taken into consideration for the estimation of the future growth of this market. The market has also been assessed on the basis of expected demand. The revenue generated from medical imaging information systems across the world have been derived using the regional pricing trends. The market data for each segment is based on the demand and the corresponding revenue.
Global Medical Imaging Information System Market: Segmentation
Broadly, the global market for medical imaging information systems is evaluated in the basis of the type of the software, end user, modality, and the regional presence of this market. Based on the type of the software, the market is bifurcated into PACS system management, radiology information systems, and integrated software solutions. By end user, the market is categorized into the Hospitals, diagnostic imaging centers, and ambulatory surgical centers (ASCs).
On the basis of the modality, the market is classified into computed tomography, positron emission tomography, magnetic resonance imaging, X-ray, ultrasound, and mammography. Geographically, the market is divided into North America, Asia Pacific excluding Japan (APEJ), the Middle East and Africa (MEA), Europe, Latin America, and Japan.
The segmentation consist of the demand for medical imaging information systems in all the regions as well as their significant economies. The patterns of the demand for these systems in each of the regions have been determined while estimating the market for various application for medical imaging information systems in them. The segmentation of this market by the end user, modality, and the type of the software has been derived through the bottom-up approach, which is accumulative of the demand from each of the regions. The regional demand for medical imaging information systems is the summation of the prominent sub-regions and the economies within a specified region.
Companies Mentioned in the Report
Varian Medical Systems, Mindray Medical International Ltd., Hitachi Medical Corp., Toshiba Corp., Fujifilm Corp., Siemens Healthcare, Koninklijke Philips N.V., Neusoft Medical Systems Ltd., Hologic Inc., GE Healthcare, and Esaote S.P.A. are some of the prominent companies in the global medical imaging information systems market.

Posted by at 1 comment:

High Content Screening Products Market is Projected to Expand at a CAGR of 8.0% from 2017 to 2022

Global High Content Screening Products Market: Overview

The report on the global high content screening products market factors in every possible driver and restraint shaping the trajectory of the market. It studies all such trends in-depth. It also segments the market based on different parameters and examines each segment thoroughly to uncover where the opportunity lies in the market. This is to help readers gather a proper idea of the market’s hierarchy and thus understand which segments to invest in.

The geographical analysis of the high content screening products market provided in the report also tries to educate savvy market players about the best regions to invest in. The report also sheds light on the competitive dynamics prevailing in the market. To do so, it leverages market leading analytical tools such a Porter’s Five Forces and SWOT Analysis. Such methods helps to gauge the opportunities and threats the market presents.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31043

As per Transparency Market Research, the global high content screening market will likely rise at a CAGR of 8.0% from 2017 to 2022 to become worth US$1.23 bn by 2022.

Global High Content Screening Products Market: Dynamics

The report discusses the various drivers affecting the growth of the global high content screening products market. It finds that regulatory factors play a key role in stoking growth. For example government support for cell-based research for creating new and more effective drugs for various diseases has been providing a fillip to the market.


The report glances at various other prevailing diseases that have provided a boost to the market. Companies wanting to bolster their positions in the global high content screening products market need to keep in mind such growth drivers to take advantage for the opportunities. The report provides readers with detailed analysis of which factors are likely to have a lasting impression on the global high content screening products market in the coming years.

Global High Content Screening Products Market: Segmentation

The report studies the segmentation of the global high content screening products market. It assesses the leading segments in the market to understand their impact on the global market’s dynamics. Consumables, microplates, instruments, software, and service are the different types high content screening products available in the market. At present the consumables dominates the market with maximum share and are predicted to clock a healthy CAGR of 8.3% in the forecast period to become worth US$486.6 mn in 2022. The high screening instruments too account for a substantial share in the market because of their cost effectiveness owing to the use of LED light engines that brings down the intensity of fluctuations and hence negates the need to switch to external illuminating sources.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31043

Among the regional markets, North America runs the show with most of the share in the global high content screening products market. Increasing prevalence of chronic diseases, a considerable population of elderly, rising collaborations of research institutes, carefully-considered mergers and acquisitions between companies, and an advanced healthcare infrastructure are some of the factors majorly fuelling the market in the region. The market in the region is predicted to clock a healthy 8.2% CAGR between 2017 and 2022. Rising at this pace it is expected to attain a value of US$402.1 mn in 2022.

Global High Content Screening Products Market: Competitive Dynamics

Thermo Fisher Scientific, Molecular Devices, GE Healthcare, PerkinElmer Inc., Becton, Dickinson and Company, Thorlabs, Inc., Merck KGaA, Cell Signaling Technology, Genedata AG, and Yokogawa Electric Corporation are to name a few key players operating in the global high content screening products market.

Posted by at No comments:

Coma Treatment Devices Market: Growth Analysis, Trends and Scope till 2024

Coma is a condition where the affected person is unconscious, unresponsive to the stimuli and cannot be woken. Coma majorly effect the brain and result from brain stroke or severe head injury. Coma can also cause by brain infection or alcohol poisoning. Other factors that responsible for coma include hypoglycemia  or hyperglycemia. The comatose persons has minimal brain activity and does not show signs of awareness. Healthcare professionals generally uses Glasgow coma scale to measure the level of consciousness for the signs of improvement or deterioration in coma patients. Generally coma patients are treated in intensive care units to ensure the condition is stable and breath and blood pressure are maintained while treating the underlying cause of the coma.
Coma treatment devices helps in monitoring the patient’s vital organ functions while ensuring the treatment of the underlying cause of the condition. These devices used to measure the blood parameters such as blood cells count, carbon monoxide, electrolytes, drugs, glucose and liver function. Apart from measuring these parameters several other instruments are used in treating the comatose patients that include computerized Tomography (CT), Magnetic Resonance Imaging (MRI), ventilators, monitors, IV pumps and electroencephalography (EEG). These devices play significant role in mapping the brain structure and functioning to ascertain the cause of the coma and helps in providing the uninterrupted treatment and breathe to the comatose patients. The feeding tubes in the ICU units used to feed the patients who are unable to eat or drink and these tubes provides breathe and drugs to the patients.
Moreover, there are a number of factors that affect the growth of the coma treatment devices market over the forecast period. Some of the key factors include, rising incidence of trauma cases, increasing number of road accidents in developing and developed countries along with increasing prevalence of chronic diseases like diabetes and epilepsy which causes coma in severe conditions are likely to create positive impact on coma treatment devices market. Other key growth drivers include recent technological advancement in coma treatment devices such as new ultrasound technique, increasing incidence of infections. The market is also witnessing restraints, or challenges in its path such as dearth of skilled ICU professionals, alongside stiff competition among existing device manufacturers. Moreover, lack of facilities in under developed countries along with lack of emergency services in developing countries are expected to restrain the growth of this market over forecast period.
This market can be categorized on three major bases such as device type, end user and geography. On the basis of device type, the market can be classified into Electroencephalogram devices, ECG devices, CT scans, Ventilators, MRI scans, monitors, IV pumps, blood parameters monitoring devices and others. Based on key end user, the coma treatment devices market can be segmented into multispecialty hospitals and ambulances.
Geographically, the coma treatment devices market can be classified into five regional markets such as North America (United States and Canada), Europe (Germany, France, United Kingdom, etc.) and Asia-Pacific (Australia, China, Japan, India, etc.), Latin America and rest of the world. The emerging markets in Asia Pacific, Latin America and the Middle East and Africa are expected to register robust growth during the forecast period 2016-2024. This would majorly be attributed to increasing incidences of trauma and brain injuries, rising prevalence of diabetes in these regions, investments by the key players operating in these countries, and growing health care industry leading to growth in the patient population in these countries. India, China and Brazil are expected to drive strong growth among the emerging countries, owing to the increasing investments by government bodies to enhance healthcare facilities.
Key companies operating in the global electrosurgical devices market are GE Healthcare, Mindray Medical, Philips Healthcare, Spacelabs Healthcare, Cadwell Laboratories Inc., BrainScope Company Inc., Lifelines Neurodiagnostic Systems Inc., Hitachi Medical Corporation, and Siemens Healthcare, Toshiba Medical Systems, Terumo Corporation.

Posted by at No comments:

Photorejuvenation Equipment Market: Segmentation, Opportunities, Trends & Future Scope to 2023


The global photorejuvenation equipment market is driven by the high popularity of these equipment for the treatment of skin disorders. This method has become increasingly popular among people as it is far cheaper than plastic surgeries. Photorejuvenation based skin treatments help with conditions such as acne, rosacea, acne scars, angioma, matted telangiectasia, red or blue facial, lentigines cherry, spider angioma, angioma, and leg veins. Thus, the global demand for photorejuvenation equipment is increasing. The growing desire to have a flawless skin is one of the key factors that has been driving the growth of this market. Skin issues such as acne and scars can rip a person of their self confidence and thus, an increasing number of people are undertaking photorejuvenation based treatments.
The increasing disposable income of people and growing importance of aesthetics and beauty have propelled the growth of the global photorejuvenation equipment market. photorejuvenation based treatment also help in removing tattoos and birthmarks, thus fueling the demand for these equipment. photorejuvenation equipment are used for hair removal too, which has become a necessity today for most women. The growing desire to stay and look young among the aging population and the increasing geriatric population are some of the other factors boosting the growth of this market. On the other hand, the growing fear of getting skin cancer in the area that has been treated is hampering the growth of this market. Hypersensitivity to light is also another factors dissuading patients from trying this method of treatment.
Photorejuvenation, one of the forms of facial rejuvenation, employs intense broad wavelength light which is absorbed by brown and red pigment beneath the skin. This process distributes energy to both epidermis and deep layers of the skin but results in some damage to the epidermis and this is minimized by applying chilled crystals. Reduction of appearance of brown spots, redness and excess blood vessels (sun damage) constitutes the primary function of Photorejuvenation treatments. In addition, it may provide a smooth and soft texture to the skin and may reduce the fine lines or wrinkles on the face. These treatments are performed on chest, neck, face, shoulders and hands. In general these treatments are performed on the areas that exhibit the signs of photo-aging.
Furthermore, Photorejuvenation therapy improves the symptoms of Rosacea and can have significant impact on the quality of life of the patients. Other treatment areas include angioma, red or blue leg veins, cherry, lentigines and matted telangiectasia, tattoo removal and birthmark removal. Various light emitting diodes (LEDs), intense pulsed light and lasers constitute photorejuvenation equipment. Photorejuvenation is performed for somewhere around 15 minutes to 45 minutes and during this process intense pulsed light is delivered to the skin through explicit filters and is passed in several settings (series of six treatments every three to four weeks) to ensure optimum results.
The absorption of light energy stimulates the production of collagen and this inturn softens the skin thereby resulting in reduction of fine lines and wrinkles. This process has been considered safe worldwide as it affects only the targeted tissues and retains the intactness of the surrounding tissues. The limitations of this process include the appearance of short term redness, darkening of age spots and bruising. Sometimes this process can be combined with facelift to render complete facial makeover.
The photorejuvenation equipment market can be segmented by technology, application and geography. Based on technology these equipment can be further sub-segmented into three broad categories namely mechanical (LED and laser), chemical (chemical peels) and thermal. Based on the application this therapy is used in treatment of acne, Rosacea, freckles and others. Geographically, North America and Europe regions exhibit large consumption of these services owing to continuously increasing population of working women and increasing preference for these treatments among elderly woman population. Safety concerns and technology skills govern the market growth.
Photorejuvenation equipment market is still in the nascent stages in Asia Pacific and Rest of the World regions, but these exhibit lucrative growth opportunities due to increasing demand for these therapies over expensive cosmetic surgeries and increasing awareness along with high disposable incomes.
Some of the major factors driving the market growth include minimally invasive nature of these procedures followed by low cost of the procedures in comparison with other surgeries. In addition, low turnaround time coupled with few side effects will further fuel the market growth. On the other hand factors such as increased risk of developing skin cancer, and adverse hypersensitivity reactions might limit the acceptance and growth of photorejuvenation equipment. Abbott Medical Optics, Biolitec AG, Lumenis Ltd., Candela Corporation, Erchonia Medical, LISA Laser Products, Alcon, Inc., Dornier Medtech GmbH, AESCULIGHT LLC, Deka Laser, Nidek Company Ltd., and Vascular Soultion, Inc. are some of the companies engaged in developing photorejuvenation equipment.
Posted by at No comments:

Pressure-Monitoring Kits Market: Review with Forecast Research Report 2017 - 2025

Measurement of vital signs is the crucial first line of treatment of any disease. Pressure is one of the most widely monitored vital signs for assessment of the health status of an individual. With rising innovations in overall transducers as well as monitors used for monitoring of several types of body pressure, the demand for proper pressure-monitoring kits continues to rise. Pressure-monitoring kits combine accessories used for pressure measurement such as transducer domes, high pressure-monitoring lines, flushing devices, infusion sets with or without luer locks, stopcocks, flush devices, and drip chambers.
The global pressure-monitoring kits market is likely to register a stable growth rate during the forecast period, owing to limited scope for product innovation and development in terms of designing and packaging. Major market players involved in the manufacture of pressure-monitoring kits are primarily focused on pressure monitors such as blood pressure monitors. However, globally increasing utilization of pressure monitors can be correlated to increased consumption of pressure-monitoring kits. This is likely to drive the global pressure-monitoring kits market during the forecast period. Some other driving factors are improved hospital infrastructure, enhanced monitoring of vital signs at outpatient settings such as acute care settings, and skilled nursing facilities. However, rapidly rising market penetration by local/emerging market players, which offer pressure-monitoring kits at lower prices owing to factors such as reduction in transportation cost, is increasing the market fragmentation. This is likely to induce pricing pressure during the forecast period.
The global pressure-monitoring kits market can be categorized based on kit type, kit model, pressure measurement type, end-user, and region. In terms of kit type, the global pressure-monitoring kits market can be segmented into single-line pressure-monitoring kits and multiple-line pressure-monitoring kits. The multiple-line pressure-monitoring kits segment can be sub-divided into double-line pressure-monitoring kits, triple-line pressure-monitoring kits, and pressure-monitoring kits with more than three lines. In terms of kit model, the market can be classified into neonatal pressure-monitoring kits, standard pressure-monitoring kits, and transducer pressure-monitoring kits. In terms of pressure measurement type, the global pressure-monitoring kits market can be divided into intracranial pressure, blood pressure, intrauterine pressure, abdominal pressure, bladder pressure, and others. Based on end-user, the market can be categorized into hospitals, clinics/specialty clinics, ambulatory surgical centers, skilled nursing facilities, long-term care centers, and others.
In terms of region, the global pressure-monitoring kits market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is likely to witness constant growth in terms of revenue during the forecast period, owing to significantly rising prevalence of hypertension and chronic pathologies requiring long-term care, improving health care infrastructure in developing countries in the region, and rising per capita health care expenditure. North America is expected to dominate the global Pressure-monitoring Kits market from 2017 to 2025, due to rising awareness about pet health checkups and increasing utilization of advanced physical examination techniques such as electronic weighing scales for animals in various industries such as milk & dairy products in the region. The overall development in techniques of the animal husbandry is likely to drive the market in North America during the forecast period.
Key players operating in the global pressure-monitoring kits market include, but are not limited to, ICU Medical, Inc., B. Braun Melsungen AG, C. R. Bard, Inc., Integra LifeSciences Corporation, Edwards Lifesciences Corporation, Lifeline Services Pvt. Ltd., and BL Lifesciences.

Posted by at No comments:

Needle Aspiration Biopsy Market Size & Share - Industry Trend and Forecast 2017 - 2025

Breast Biopsy is removal of cells or tissues from doubtful areas of breast. These cells or tissues are studied under a microscope to verify the presence of cancer. When a hollow needle is used to remove tissue samples from breast, it is known as core needle biopsy. It is the typical way to rule out or diagnose breast cancer. Core needle biopsy is done for the palpable mass or lump that can be felt, or suspicious area which is seen after mammogram or imaging test. Fine needle biopsy, also known as fine needle aspiration, removes the cells from suspicious lump in breast. The needle used for fine needle biopsy is thinner than the needle used for core needle biopsy. According to the American Cancer Society, 252,710 new cases of invasive breast cancer are projected to be diagnosed in women in the U.S. in 2017. About 63,410 new cases of carcinoma in situ (CIS) are anticipated to be diagnosed (CIS is non-invasive and is the earliest form of breast cancer). About 40,610 women are expected to die from breast cancer.
Different types of biopsies are core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, image-guided biopsy, incisional biopsy, excisional biopsy, shave biopsy, punch biopsy, endoscopic biopsy, and bone marrow aspiration & biopsy. Two major types of biopsies are needle biopsy and surgical biopsy. Needle biopsy involves usage of a needle to remove tissue sample. Surgical biopsy involves an incision to collect tissue sample. Core needle biopsy is done in imaging centers or hospitals. It is an image guided biopsy procedure. Advantages of core needle biopsy and fine needle biopsy are least chance of bruising or infection. If the lump is confirmed benign, then surgical biopsy is not required. However, there is a chance that the needle may miss the tumor cells, and hence misinterpret it as non-cancerous cell. Fine needle aspiration has false negative rate of 2% to 4%. Hence, fine needle aspiration can be followed by core needle biopsy or surgical biopsy.
Based on utility, the global needle aspiration biopsy market can be categorized into disposable and reusable. In terms of application, the market can be segmented into tumor, inflammation, infection, and others. Based on end-user, the global needle aspiration biopsy market can be classified into diagnostic & imaging centers, hospitals, academics & research centers, and others. Increase in prevalence and incidence of cancer globally and rise in awareness about diseases are the major factors fueling the growth of the global needle aspiration biopsy market. However, technological advancements in imaging such as computed tomography and magnetic resonance imaging are likely to restrain the global needle aspiration biopsy market. Emergence of fluid biopsy can also hamper the growth of the market.
The global needle aspiration biopsy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to reflect a high CAGR due to significant patient population. Growing awareness among patients as well as health care professionals has led to increase in number of diagnosed cases of cancer in Asia, especially in China and India. North America is projected to dominate the global needle aspiration biopsy market due to factors such as rise in number of reported cancer cases, high per capita health expenditure, and significant investment in R&D for effective treatment alternatives.
Key players in the global needle aspiration biopsy market include Cook Medical, Boston Scientific Corporation, Hologic, Inc., Medax Srl Unipersonale, Cardinal Health, Inc., C. R. Bard, Inc., Becton, Dickinson and Company, Leica Biosystems Nussloch GmbH, Möller Medical GmbH, Hakko Co. Ltd., Argon Medical Devices, Inc., and COMPASS International Innovations, Inc.
Posted by at No comments:

Arterial Stents Market Opportunity will Rise to US$ 17.8 Bn by 2025

Global Arterial Stents Market: Overview
Choc-o-bloc with small regional as well as large global players, the global market for arterial stents is highly fragmented. In order to thrive in such a fragmented competitive landscape, big ticket players are seen banking upon effective clinical trials to come up with better products. Despite, involved regulatory approvals, they are charging ahead. A noticeable trend in the market is the usage of nickel titanium alloys and other alloys to build new and better products. Savvy players are also seen collaborating with regulatory agencies in order to further gain a foothold in the market.
Global Arterial Stents Market: Key Trends
Acting as tailwinds to the global market for arterial stents is the rising occurrence of arterial issues,  including atherosclerosis. Arterial stents are seeing their popularity grow by the day because of their efficiency in tackling coronary and peripheral artery diseases and also because of the rising knowledge about such minimally invasive methods to open up arteries that carry blood in the human body. Launch of more cutting-edge arterial stents every now and then is proving beneficial for the market too. However, despite so many drivers, the market is being prevented from achieving its full potential because of the dearth of advanced healthcare institutions and highly-skilled interventional cardiologists in developing nations.
The arterial stents being sold in the market can be broadly classified into peripheral stents and coronary stents. The peripheral stents mostly comprise of balloon-expanding stents, self-expanding stents, and others such as drug-eluting stents and covered stents. The coronary stents, on the other hand, consist of bare metal stents, bioresorbable stents, drug-eluting stents, and others such as covered stents and dual-therapy stents. Between coronary and peripheral stents, the former has been grossing most of the revenue on the back of unique products, namely bioresorbable stents highly preferred by interventional cardiologists. Another hit product making significant revenues is drug-eluting stent. Peripheral stents, going forward however, are predicted clock greater growth.
Application-wise, the key segments of the global market for arterial stents market are iliac artery, coronary artery, femoral and popliteal artery, and carotid artery, among others such as renal and biliary artery, below-the knee artery, etc.
Global Arterial Stents Market: Regional Outlook
From a geographical standpoint, Europe accounts for a dominant share in the market for arterial stents mainly because of many prominent manufacturers being domiciled in the nations of the U.K. and Germany. Strong uptake of minimally invasive surgeries in the region has also helped its market. While Europe region takes the lead when it comes to market share, Asia Pacific surpasses others vis-à-vis growth rate. Highly populous, fast expanding economies of China and India, seeing large scale upgrading of their healthcare sector, are mainly said to be powering the growth in Asia Pacific.
Global Arterial Stents Market: Competitive Dynamics
Some of the prominent participants in the global market for arterial stents are Medtronic, Abbott Laboratories, Cordis Corporation, C.R. Bard Inc., Boston Scientific Corporation, Gore Medical, Cook Medical, Lifetech Scientific, Biosensors International Group Ltd., and BIOTRONIK AG.

Posted by at No comments:

Spinal Fusion Devices Market to Attain a Value of US$ 10.96 Bn by 2025

Global Spinal Fusion Devices Market: Overview
Spinal fusion can be defined as the orthopedic procedure which involves the fusion of two or more vertebrae to restrict the movement of the affected vertebrae and to reduce the pain suffered by the patient. A range of spinal fusion procedures are performed covering the thoracic, lumbar, and cervical areas of the spine.
The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of spinal fusion devices employed in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product type, surgery, end-user, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each product type and end-user was calculated by considering the number of spinal fusion procedures performed globally. In addition, the regional trends of these devices, the geriatric population, increasing obesity, and the rise in the number of spine diseases were considered.
Global Spinal Fusion Devices Market: Scope of Study
The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, surgery, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the spinal fusion devices market in the current and future scenario. The report also provides the pipeline products, the CPT codes of reimbursement for the spinal fusion procedures, the regulatory approval process, porter’s five force analysis, and the key industry developments.
Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the spinal fusion devices market.
Global Spinal Fusion Devices Market: Competitive Landscape
The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the spinal fusion devices market report are Major players in the spinal fusion devices market include Stryker Corporation, NuVasive, Inc., Globus Medical Inc., Orthofix International N.V., Zimmer Biomet Holdings, Inc., Medtronic plc, K2M Group Holdings, Inc., Alphatec Holdings, Inc., Exactech, Inc., B. Braun Melsungen AG, Depuy Synthes (a part of Johnson & Johnson), and Titan Spine, LLC, among others.
Posted by at No comments:

Breast Pumps Market is Expanding at a CAGR of 8.9% from 2017 to 2025



Global Breast Pumps Market: Overview
The report on the breast pumps market analyzes the current and future scenario of the global market. Government initiatives in creating awareness on benefits of breastfeeding, rising working women population worldwide, rising demand for breastfeeding products, and advancement of breast pumps technologies by major key players are the major drivers of the global breast pumps market.
The breast pumps market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global breast pumps market with respect to the segments based on product, applications and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global breast pumps market.
Global Breast Pumps Market: Key Segments
Based on product, the breast pumps market is segmented as single electric breast pumps, double electric breast pumps, and manual breast pumps. The product market segments have been analyzed based on available products in markets, technological advancement in products development, demand for single electric, double electric and manual breast pumps products, cost-effectiveness, and preference for different types of breast pumps among consumers. The market size and forecast in terms of value (US$ Mn) & volume (Units) for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on applications, breast pumps market is segmented into hospital grade and personal use. The market segments have been extensively analyzed based on availability of hospital grade and
personal use breast pumps in the market, pricing of hospital grade and personal use breast pumps, and demand for hospital grade and personal use breast pumps product among consumers and geographical coverage. The market size and forecast in terms of value (US$ Mn) & volume (Units) for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Breast Pumps Market: Regional Outlook
Geographically, the global breast pumps market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa and Rest of Middle East & Africa). The market size and forecast in terms of value (US$ Mn) and volume (Units) for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global breast pumps market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Medela LLC., Pigeon Group (Pigeon Corporation), Koninklijke Philips N.V., Ameda, Inc., Ardo Medical Ag, Evenflo Feeding, Inc., Mayborn Group Limited (Shanghai Jahwa Co. Ltd), Spectra Baby USA, Albert Manufacturing USA (Albert Group), Hygeia Health and others.
Posted by at No comments:
Subscribe to: Posts (Atom)